How quickly does Tirzepatide reduce appetite?

Many users notice a significant reduction in hunger and food intake within the first 1-2 weeks of starting Tirzepatide, even at the lowest starting dose of 2.5mg/week.

What is the difference between the 5mg and 10mg Tirzepatide vials?

Both contain the same active substance at different total concentrations. The 5mg vial suits starting doses and standard maintenance (2.5-5mg/week), while the 10mg vial is more practical for advanced maintenance doses (7.5-10mg/week) without needing multiple vials.

Does Tirzepatide cause muscle loss?

Significant weight loss from any source, including Tirzepatide, can include some loss of lean mass alongside fat mass if protein intake and resistance training are not maintained. Adequate protein intake and continued training help preserve muscle during the weight loss process.

How long does it take to reconstitute and use Tirze-Pep?

Reconstitution takes only a few minutes — add bacteriostatic water slowly along the vial wall and swirl gently until fully dissolved. Once reconstituted, the vial should be refrigerated and is typically usable for several weeks, though always check the specific guidance for your batch.

Why does Tirzepatide need to be titrated slowly?

Gradual titration — typically increasing the dose every 4 weeks — allows the body to adjust to the GLP-1/GIP mechanism, significantly reducing the nausea and gastrointestinal discomfort that can occur with larger initial doses.

Can Tirzepatide be used alongside a steroid cycle?

Yes. Tirzepatide does not interact with androgen receptors or the HPG axis, so it does not affect testosterone levels or interfere with AAS pharmacology. It can be used independently, alongside a cycle, or during PCT without any hormonal interaction.

What happens if I miss a weekly Tirzepatide dose?

If a dose is missed by a day or two, it can typically be taken as soon as remembered, then continue on the regular weekly schedule. If significantly more time has passed, restarting at a lower dose may be advisable — consult dosing guidance for your specific titration stage.

Tirze-Pep — Tirzepatide 5mg GLP-1/GIP Peptide Vial USA

Name: Tirzepatide by Dragon Pharma
Brand: Dragon Pharma
SKU: OFFER-3893
Price: 99.0 USD
Availability: InStock

Tirzepatide — Tirze-Pep by Dragon Pharma

Tirze-Pep is Dragon Pharma's formulation of Tirzepatide at 5mg per vial — a dual GLP-1/GIP receptor agonist and one of the most extensively studied peptides for appetite control, glucose regulation and weight management. Supplied as a lyophilised vial requiring reconstitution, Tirze-Pep is dosed via weekly subcutaneous injection.

Also searched as: Tirzepatide 5mg, GLP-1 GIP peptide, Tirze-Pep Dragon Pharma, tirzepatide vial.

What Is Tirzepatide?

Tirzepatide is a synthetic peptide that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors — a dual mechanism that distinguishes it from single-action GLP-1 compounds. This combined receptor activity slows gastric emptying, increases satiety, and improves insulin sensitivity, resulting in significant appetite reduction and supporting substantial reductions in body weight in clinical research. Tirzepatide does not interact with androgen receptors or the HPG axis and does not suppress natural testosterone production.

Effects and Benefits

Significant appetite reduction — most users report a marked decrease in hunger and food intake within the first 1-2 weeks
Slowed gastric emptying, contributing to prolonged satiety after meals
Improved insulin sensitivity and glucose regulation
Substantial body weight reduction supported by extensive clinical research at therapeutic doses
No suppression of natural testosterone — does not require Post Cycle Therapy

Dosage and Administration

Phase	Typical Dose	Duration
Starting dose	2.5 mg	Weeks 1–4
Titration	5 mg	Weeks 5–8 (if tolerated)
Maintenance / advanced	7.5–10 mg	Ongoing, titrated gradually

Tirzepatide is dosed once weekly via subcutaneous injection, with the dose typically titrated upward gradually every 4 weeks to minimise gastrointestinal side effects. The 5mg Tirze-Pep vial provides flexibility for both starting doses (drawing a partial dose) and standard maintenance dosing at the full 5mg mark. For users requiring higher maintenance doses, Dragon Pharma also offers Tirzepatide 10mg.

Side Effects

Tirzepatide's side effects are primarily gastrointestinal and dose-dependent, most pronounced during dose increases:

Nausea, particularly during the first days after a dose increase — typically subsides as the body adjusts
Reduced appetite can, if excessive, lead to inadequate caloric or protein intake — monitoring intake remains important even with appetite suppression
Constipation or diarrhoea in some users, related to the slowed gastric emptying mechanism
Injection site reactions are possible but generally mild
No impact on testosterone, estrogen or the HPG axis — does not require PCT

Tirze-Pep 5mg vs Tirzepatide 10mg

Dragon Pharma offers Tirzepatide in two vial strengths:

Tirze-Pep (5mg vial) — suited to starting doses and standard maintenance protocols (2.5-5mg/week)
Tirzepatide 10mg vial — suited to advanced maintenance doses (7.5-10mg/week) without requiring multiple vials

Most users beginning Tirzepatide should start with the 5mg vial, as the titration schedule begins well below this concentration. Users who have titrated up to 7.5mg/week or higher may find the 10mg vial more practical for ongoing maintenance.

Reconstitution and Storage

Tirze-Pep is supplied as a lyophilised powder requiring reconstitution with bacteriostatic water before use. Add the bacteriostatic water slowly along the vial wall and swirl gently — do not shake. Store the reconstituted vial refrigerated at 2-8°C, and use within the timeframe indicated on the product label. Never freeze a reconstituted peptide vial.

"Tirze-Pep is formulated as a high-purity 5mg Tirzepatide vial, reflecting the dual GLP-1/GIP mechanism behind one of the most researched peptides for weight management. It remains one of our most requested peptide products."